Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Recurrence Versus Uncontrolled Disease in Chronic Rhinosinusitis with Nasal Polyps: A Scoping Review of Conceptual and Operational Definitions.

Created on 09 Nov 2026

Authors

Daniel Martin-Jimenez, Meritxell Clari-Comes, Adriana Izquierdo-Dominguez, Ramon Moreno-Luna, Isam Alobid

Published in

Current allergy and asthma reports. Volume 26. Issue 1. Nov 09, 2026. Epub Nov 09, 2026.

Abstract

To clarify the conceptual and operational distinctions between recurrence and uncontrolled disease in chronic rhinosinusitis with nasal polyps (CRSwNP).
Five databases yielded 2,488 unique records from 2012 to 2026; 44 sources were ultimately included after independent screening and duplicate charting using a piloted form, including two peer-reviewed manuscripts accepted for publication. Recurrence and uncontrolled disease shared assessment domains encompassing patient-perceived burden, objective inflammatory activity and treatment requirements, but differed in temporal structure, reference state, operational rules and clinical purpose. Recurrence definitions were concentrated after endoscopic sinus surgery (ESS) and ranged from endoscopic nasal polyp regrowth or revision ESS to multidimensional worsening after a previous improved state. Uncontrolled disease was applied across medical, surgical and biologic settings to classify the acceptability of current burden without requiring previous improvement. Crossing disease trajectory with current control supported a four-pattern conceptual map. Persistent uncontrolled disease without recurrence and recurrence with maintained control represented the two discordant patterns in which the distinction between both constructs became most evident. Treatment response, disease remission, treatment failure and escalation provided related but non-equivalent information. Recurrence and uncontrolled disease capture complementary but non-interchangeable dimensions of CRSwNP. Shared measurement domains do not establish equivalence, and neither construct can be inferred from the other. Separate assessment of trajectory and current control, interpreted alongside treatment response, duration of benefit, previous therapy and patient priorities, may improve outcome reporting and provide a more precise basis for therapeutic decisions. Prospective studies should determine whether this two-dimensional approach adds prognostic and clinical value to existing frameworks.

PMID:
43002191
Bibliographic data and abstract were imported from PubMed on 09 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement